Prosecution Insights
Prosecution Insights
Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Blackfly Investments LLC Dba Molecular Testing Labs is currently addressing 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are spread across 3 distinct examiners and 2 distinct art units. This distribution indicates that the company is managing intellectual property across multiple specialized examination groups. The involvement of the art units suggests a slight technical divergence in the applications being prosecuted.
The busiest examiner for the portfolio is MUSTANSIR, ABID A, who is responsible for 1 pending office action. Given that there are pending office actions and distinct examiners, each examiner is managing a single matter. Practitioners should note that the 2 distinct art units involved may apply different examination standards to the pending office actions. This requires a strategy that accounts for the specific nuances of the examiners across the different organizational units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUSTANSIR, ABID A | 1 | 78.5% | +10.3% |
| KREMER, MATTHEW | 1 | 43.6% | +52.2% |
| COOLEY, CHARLES E | 1 | 79.0% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18379973 | Objective Dried Blood Spot Collection Device | KREMER, MATTHEW | 33d |
| 19011150 | Microtube Cap Having Built-In Compartment for Stabilizer Suited for Remote Blood Collection | MUSTANSIR, ABID A | — |
| 18208567 | System and Method for Centrifuging Using an Anti-Parallel Rotor Attachment | COOLEY, CHARLES E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18379973 | Objective Dried Blood Spot Collection Device | KREMER, MATTHEW | 33d |
| 19011150 | Microtube Cap Having Built-In Compartment for Stabilizer Suited for Remote Blood Collection | MUSTANSIR, ABID A | — |
| 18208567 | System and Method for Centrifuging Using an Anti-Parallel Rotor Attachment | COOLEY, CHARLES E | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19011150 | Microtube Cap Having Built-In Compartment for Stabilizer Suited for Remote Blood Collection | MUSTANSIR, ABID A | 3791 | §103§112 | Non-Final OA | — | Pending | Jan 06, 2025 |
| 18379973 | Objective Dried Blood Spot Collection Device | KREMER, MATTHEW | 3791 | §103§112 | Non-Final OA | 33d | Pending | Oct 13, 2023 |
| 18208567 | System and Method for Centrifuging Using an Anti-Parallel Rotor Attachment | COOLEY, CHARLES E | 1774 | §102§112 | Non-Final OA | — | Pending | Jun 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial